Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Journal of the American Veterinary Medical Association
|
October 15, 1981
Effect of acetazolamide in blood acid-base and electrolyte values in dogs
S C Haskins, R J Munger, M G Helphrey, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Treatment of malignant gliomas with interstitial irradiation and hyperthermia
B Stea, J Kittelson, J R Cassady, et al.
Selective Cancer Therapeutics
|
January 1, 1990
Forbeck forum on improved drug delivery to brain tumors
A I Freeman, J Fenstermacher, W Shapiro, et al.
Cell Reports
|
April 24, 2024
Batf3<sup>+</sup> DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy
Andrea Ziblat, Brendan L Horton, Emily F Higgs, et al.
Plos One
|
November 19, 2016
Genomes of Gardnerella Strains Reveal an Abundance of Prophages within the Bladder Microbiome
Kema Malki, Jason W Shapiro, Travis K Price, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
May 3, 2021
Bringing Cultural Competency to the EHR: Lessons Learned Providing Respectful, Quality Care to the LGBTQ Community
Aliasgar Z Chittalia, Heather L Marney, Spencer Tavares, et al.
Cancer Immunology Research
|
June 13, 2025
Tumor cell-intrinsic Decr2 regulates ferroptosis and immunotherapy efficacy
Shuyin Li, Jason W Shapiro, Hardik Shah, et al.
Cancer Research
|
February 15, 1996
Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine
M Belanich, M Pastor, T Randall, et al.
British Journal of Cancer
|
August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
W K Yung, R E Albright, J Olson, et al.
British Journal of Cancer
|
February 13, 2001
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine
K A Jaeckle, S Phuphanich, M J Bent, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Journal of the American Veterinary Medical Association
|
October 15, 1981
Effect of acetazolamide in blood acid-base and electrolyte values in dogs
S C Haskins, R J Munger, M G Helphrey, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Treatment of malignant gliomas with interstitial irradiation and hyperthermia
B Stea, J Kittelson, J R Cassady, et al.
Selective Cancer Therapeutics
|
January 1, 1990
Forbeck forum on improved drug delivery to brain tumors
A I Freeman, J Fenstermacher, W Shapiro, et al.
Cell Reports
|
April 24, 2024
Batf3<sup>+</sup> DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy
Andrea Ziblat, Brendan L Horton, Emily F Higgs, et al.
Plos One
|
November 19, 2016
Genomes of Gardnerella Strains Reveal an Abundance of Prophages within the Bladder Microbiome
Kema Malki, Jason W Shapiro, Travis K Price, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
May 3, 2021
Bringing Cultural Competency to the EHR: Lessons Learned Providing Respectful, Quality Care to the LGBTQ Community
Aliasgar Z Chittalia, Heather L Marney, Spencer Tavares, et al.
Cancer Immunology Research
|
June 13, 2025
Tumor cell-intrinsic Decr2 regulates ferroptosis and immunotherapy efficacy
Shuyin Li, Jason W Shapiro, Hardik Shah, et al.
Cancer Research
|
February 15, 1996
Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine
M Belanich, M Pastor, T Randall, et al.
British Journal of Cancer
|
August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
W K Yung, R E Albright, J Olson, et al.
British Journal of Cancer
|
February 13, 2001
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine
K A Jaeckle, S Phuphanich, M J Bent, et al.
Page
of 14